skip to main content

THE URGENCY OF MEDICAL MARIJUANA LAWS IN INDONESIA

*Amarta Yasyhini Ilka Haque  -  Supreme Court of the Republic of Indonesia, Indonesia
Muh Endriyo Susila orcid scopus  -  Faculty of Law, Universitas Muhammadiyah Yogyakarta, Indonesia
Open Access Copyright (c) 2024 Diponegoro Law Review under http://creativecommons.org/licenses/by-nc-sa/4.0.

Citation Format:
Abstract

Marijuana legalization remains a contentious public health issue in Indonesia. Despite public debates sparked by a mother's appeal for medicinal marijuana last June, Indonesia maintains strict anti-drug measures under its Narcotics Law, which prohibits the use of all elements of marijuana in medical treatments. However, medicinal marijuana has gained recognition in other jurisdictions for its potential to treat various chronic illnesses. This study employs a doctrinal legal research methodology, relying on secondary sources, legislation, and scholarly analyses. The findings emphasize the urgent need to legalize medicinal marijuana as a critical intervention for specific medical conditions. While possession and use of marijuana remain illegal, Indonesia's ratification of the Single Convention on Narcotic Drugs 1961 allows for research and the controlled use of medicinal marijuana. By examining the experiences of nations with established medical marijuana legislation and emphasizing further research on its applications, this study advocates for the legalization of medicinal marijuana in Indonesia under stringent regulations.

Note: This article has supplementary file(s).

Fulltext View|Download |  common.other
Turnitin Result
Subject
Type Other
  Download (3MB)    Indexing metadata
Keywords: Marijuana Law; Human Rights; Marijuana Legalization
Funding: Universitas Muhammadiyah Yogyakarta

Article Metrics:

  1. Single Convention on Narcotic Drugs. Accessed October 9, 2022. https://www.unodc.org/pdf/convention_1961_en.pdf
  2. Abbiyyu, Mohammad Darry. “Strategi Gerakan Lingkar Ganja Nusantara Dalam Memperjuangkan Legalisasi Ganja Di Indonesia.” Jurnal Politik Muda 5, no. 3 (2016): 300–310
  3. Acevedo, Beatriz. “Creating the Cannabis User: A Post-Structuralist Analysis of the Re-Classification of Cannabis in the United Kingdom (2004–2005).” International Journal of Drug Policy 18, no. 3 (2007): 177–86. https://doi.org/10.1016/j.drugpo.2006.11.008
  4. Arbi, Ivany Atina. “Kupang Court Sends Man to Jail for Consuming Marijuana for Medical Use - National - The Jakarta Post,” June 23, 2020. https://www.thejakartapost.com/news/2020/06/22/kupang-court-sends-man-to-jail-for-consuming-marijuana-for-medical-use.html
  5. Aso, Ester, and Isidre Ferrer. “Cannabinoids for Treatment of Alzheimer’s Disease: Moving toward the Clinic.” Frontiers in Pharmacology 5 (2014): 37. https://doi.org/10.3389/fphar.2014.00037
  6. Baird, Carolyn. “Marijuana and Medicinal Marijuana: A Global Perspective.” Journal of Addictions Nursing 30, no. 2 (2019): 125–27. https://doi.org/10.1097/JAN.0000000000000280
  7. BBC News. “Legalisasi Ganja Untuk Keperluan Medis Ditolak MK - BBC News Indonesia,” July 20, 2022. https://www.bbc.com/indonesia/articles/c19m3k9wvmvo
  8. ———. “Menteri Kesehatan Akan Izinkan Riset Ganja, Bagaimana Dampaknya Terhadap Upaya Legalisasi Untuk Keperluan Medis? - BBC News Indonesia,” July 4, 2022. https://www.bbc.com/indonesia/indonesia-61977271
  9. Bewley-Taylor, David, and Martin Jelsma. “Fifty Years of the 1961 Single Convention on Narcotic Drugs: A Reinterpretation.” Series on Legislative Reform of Drug Policies 12 (2011): 1–20
  10. ———. “Regime Change: Re-Visiting the 1961 Single Convention on Narcotic Drugs.” International Journal of Drug Policy 23, no. 1 (2012): 72–81. https://doi.org/10.1016/j.drugpo.2011.08.003
  11. Bradford, Ashley C, and W David Bradford. “Medical Marijuana Laws May Be Associated with a Decline in the Number of Prescriptions for Medicaid Enrollees.” Health Affairs 36, no. 5 (2017): 945–51. https://doi.org/10.1377/hlthaff.2016.1135
  12. Buenz, E J, H E Johnson, E M Beekman, T J Motley, and B A Bauer. “Bioprospecting Rumphius’s Ambonese Herbal: Volume I.” Journal of Ethnopharmacology 96, no. 1–2 (2005): 57–70. https://doi.org/10.1016/j.jep.2004.08.016
  13. Calandrillo, Steve P, and Katelyn Fulton. “High Standards: The Wave of Marijuana Legalization Sweeping America Ignores the Hidden Risks of Edibles.” Ohio State Law Journal 80, no. 2 (2019): 201
  14. Case No.111/Pid.Sus/2017/PN.Sag
  15. Caulley, Lisa, Benjamin Caplan, and Edgar Ross. “Medical Marijuana for Chronic Pain.” The New England Journal of Medicine 379, no. 16 (2018): 1575–77
  16. Chu, Yu-Wei Luke, and Wilbur Townsend. “Joint Culpability: The Effects of Medical Marijuana Laws on Crime.” Journal of Economic Behavior & Organization 159 (2019): 502–25
  17. D’Amico, Elizabeth J, Joan S Tucker, Eric R Pedersen, and Regina A Shih. “Understanding Rates of Marijuana Use and Consequences among Adolescents in a Changing Legal Landscape.” Current Addiction Reports 4, no. 4 (2017): 343–49. https://doi.org/10.1007/s40429-017-0170-y
  18. Englund, Amir, Tom P Freeman, Robin M Murray, and Philip McGuire. “Can We Make Cannabis Safer?” The Lancet Psychiatry 4, no. 8 (2017): 643–48. https://doi.org/10.1016/S2215-0366(17)30075-5
  19. Ferdinan. “BNN Rejects Legalization Of Marijuana, Affirms Narcotics Category 1 Is Not Allowed For Drug Purposes,” July 5, 2022. https://voi.id/en/berita/186713/bnn-tolak-legalisasi-ganja-tegaskan-narkotika-golongan-1-tak-diperbolehkan-untuk-kepentingan-obat
  20. Fischer, Benedikt, Sharan Kuganesan, and Robin Room. “Medical Marijuana Programs: Implications for Cannabis Control Policy–Observations from Canada.” International Journal of Drug Policy 26, no. 1 (2015): 15–19. https://doi.org/10.1016/j.drugpo.2014.09.007
  21. Fitzcharles, Mary-Ann, and Shahin Jamal. “Expanding Medical Marijuana Access in Canada: Considerations for the Rheumatologist.” The Journal of Rheumatology 42, no. 2 (2015): 143–45. https://doi.org/10.3899/jrheum.131514
  22. Friese, Bettina, and Joel W Grube. “Legalization of Medical Marijuana and Marijuana Use among Youths.” Drugs: Education, Prevention and Policy 20, no. 1 (2013): 33–39. https://doi.org/10.3109/09687637.2012.713408
  23. Gondokesumo, Marisca Evalina, and Nabbilah Amir. “Legality Of Marijuana Use In The Need For Medical Treatment In Indonesia (Judging From Law Number 36 Of 2009 Concerning Health And Law Number 35 Of 2009 Concerning Narcotics).” Journal Equity of Law and Governance 1, no. 2 (2021): 119–26. https://doi.org/10.55637/elg.1.2.3938.119-126
  24. Hines, Larissa, Jill Glick, Kristin Bilka, and John D Lantos. “Medical Marijuana for Minors May Be Considered Child Abuse.” Pediatrics 142, no. 4 (2018). https://doi.org/10.1542/peds.2017-4310
  25. Hoffmann, Diane E, and Ellen Weber. “Medical Marijuana and the Law.” New England Journal of Medicine 362, no. 16 (2010): 1453–57
  26. Idham, Gunawan Widjaja. “Legal Politics of Medical Cannabis in Indonesia.” Multicultural Education 7, no. 6 (2021): 297–300. https://doi.org/10.5281/zenodo.4975526
  27. Johnson, Julie, Dominic Hodgkin, and Sion Kim Harris. “The Design of Medical Marijuana Laws and Adolescent Use and Heavy Use of Marijuana: Analysis of 45 States from 1991 to 2011.” Drug and Alcohol Dependence 170 (2017): 1–8. https://doi.org/10.1016/j.drugalcdep.2016.10.028
  28. Kępski, Piotr. “Defining ‘the Marijuana Problem’: An Analysis of the Polish Daily Press, 2015–2016.” Nordic Studies on Alcohol and Drugs 38, no. 4 (2021): 361–76. https://doi.org/10.1177/1455072520936807
  29. Law No 35 of 2009 concerning Narcotics of the Republic of Indonesia
  30. Li, Yi, and Guang Guo. “Heterogeneous Peer Effects on Marijuana Use: Evidence from a Natural Experiment.” Social Science & Medicine 252 (2020): 112907. https://doi.org/10.1016/j.socscimed.2020.112907
  31. Llewellyn, Aisyah. “Indonesian Mothers Fight for Medical Marijuana for Their Children | Health News | Al Jazeera,” August 10, 2022. https://www.aljazeera.com/news/2022/8/10/indonesian-mothers-fight-for-medical-marijuana-for-their-children
  32. Martin, Jennifer H, and Yvonne A Bonomo. “Medicinal Cannabis in Australia: The Missing Links.” Medical Journal of Australia 204, no. 10 (2016): 371–73. https://doi.org/10.5694/mja16.00234
  33. Mead, Alice. “Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States.” Frontiers in Plant Science 10 (2019): 697. https://doi.org/10.3389/fpls.2019.00697
  34. Mikuriya, Tod H. “Marijuana in Medicine: Past, Present and Future.” California Medicine 110, no. 1 (1969): 34
  35. Murdomo, J S, Vidya Ratri Ramadhani, Jovan Ramadhan Gomang, Dery Yoga Wibiyanto, and Lanjar Jalu Nugroho. “Pandangan Hukum Pidana Terhadap Legalisasi Ganja Di Indonesia.” Jurnal Kajian Hukum 6, no. 1 (2021): 12–19
  36. Pangaribuan, Aristo Marisi Adiputra, and Kelly Manthovani. “Causes and Consequences of the War on Marijuana in Indonesia.” Indonesia Law Review 9, no. 2 (2019): 22. https://doi.org/10.15742/ilrev.v9n2.502
  37. Paoki, Viku, and Haniah Hanafie. “LGN Sebagai Kelompok Kepentingan (Studi Upaya Lingkar Ganja Nusantara (LGN) Dalam Perubahan UU No. 3 Tahun 2009 Tentang Narkotika).” Independen 2, no. 1 (2021): 33–40. https://doi.org/10.24853/independen.2.1.33-40
  38. Park, Ji-Yeun, and Li-Tzy Wu. “Prevalence, Reasons, Perceived Effects, and Correlates of Medical Marijuana Use: A Review.” Drug and Alcohol Dependence 177 (2017): 1–13. https://doi.org/10.1016/j.drugalcdep.2017.03.009
  39. Putranto, Mahardian, and Yovita Arie Mangesti. “Penggunaan Ganja Medis Dalam Pengobatan Dan Pengaturannya Di Indonesia.” Journal Evidence Of Law 3, no. 1 (2024): 10–19. https://doi.org/10.59066/jel.v3i1.582
  40. Putri, Dania, and Tom Blickman. “Cannabis in Indonesia.” Drug Policy Briefing 44 (2016): 1–24
  41. Resko, Stella M, Kathryn A Szechy, Theresa J Early, Jennifer D Ellis, Danielle Hicks, and Elizabeth Agius. “Perceptions of Public Health Consequences of Marijuana Legalization.” Addiction Research & Theory 29, no. 3 (2021): 255–62. https://doi.org/10.1080/16066359.2020.1823971
  42. Rieder, Michael J, Canadian Paediatric Society, and Drug Therapy and Hazardous Substances Committee. “Is the Medical Use of Cannabis a Therapeutic Option for Children?” Paediatrics & Child Health 21, no. 1 (2016): 31–34. https://doi.org/10.1093/pch/21.1.31
  43. Salomonsen-Sautel, Stacy, Joseph T Sakai, Christian Thurstone, Robin Corley, and Christian Hopfer. “Medical Marijuana Use among Adolescents in Substance Abuse Treatment.” Journal of the American Academy of Child & Adolescent Psychiatry 51, no. 7 (2012): 694–702. https://doi.org/10.1016/j.jaac.2012.04.004
  44. Sandberg, Sveinung. “Cannabis Culture: A Stable Subculture in a Changing World.” Criminology & Criminal Justice 13, no. 1 (2013): 63–79. https://doi.org/10.1177/1748895812445620
  45. Sarma, Nandakumara D, Andrew Waye, Mahmoud A ElSohly, Paula N Brown, Sytze Elzinga, Holly E Johnson, Robin J Marles, Jeremy E Melanson, Ethan Russo, and Lawrence Deyton. “Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes.” Journal of Natural Products 83, no. 4 (2020): 1334–51. https://dx.doi.org/10.1021/acs.jnatprod.9b01200
  46. Sarvet, Aaron L, Melanie M Wall, David S Fink, Emily Greene, Aline Le, Anne E Boustead, Rosalie Liccardo Pacula, Katherine M Keyes, Magdalena Cerdá, and Sandro Galea. “Medical Marijuana Laws and Adolescent Marijuana Use in the United States: A Systematic Review and Meta‐analysis.” Addiction 113, no. 6 (2018): 1003–16
  47. Sznitman, Sharon R, and Nehama Lewis. “Is Cannabis an Illicit Drug or a Medicine? A Quantitative Framing Analysis of Israeli Newspaper Coverage.” International Journal of Drug Policy 26, no. 5 (2015): 446–52. http://dx.doi.org/10.1016/j.drugpo.2015.01.010
  48. United Nations. “CND Votes on Recommendations for Cannabis and Cannabis-Related Substances.” Accessed October 9, 2022. https://www.unodc.org/unodc/en/frontpage/2020/December/cnd-votes-on-recommendations-for-cannabis-and-cannabis-related-substances.html
  49. Velasco, G, C Sánchez, and M Guzmán. “Anticancer Mechanisms of Cannabinoids.” Current Oncology 23, no. s1 (2016): 23–32. http://dx.doi.org/10.3747/co.23.3080
  50. Volkow, Nora D, Ruben D Baler, Wilson M Compton, and Susan R B Weiss. “Adverse Health Effects of Marijuana Use.” New England Journal of Medicine 370, no. 23 (2014): 2219–27. https://doi.org/10.1056/NEJMra1402309
  51. Whiting, Penny F, Robert F Wolff, Sohan Deshpande, Marcello Di Nisio, Steven Duffy, Adrian V Hernandez, J Christiaan Keurentjes, Shona Lang, Kate Misso, and Steve Ryder. “Cannabinoids for Medical Use: A Systematic Review and Meta-Analysis.” Jama 313, no. 24 (2015): 2456–73. https://doi.org/10.1001/jama.2015.6358
  52. Widjaja, Gunawan. “Should Cannabis as Medicine Be Specifically Regulated?” Genus 3, no. 3 (2018). https://doi.org/10.15416/pcpr.v3i3.19979
  53. Wirawan, Jerome, and Oke Budhi. “‘Ganja Untuk Obat,’ Terbukti Atau Sekadar Akal-Akalan? - BBC News Indonesia,” May 3, 2017. https://www.bbc.com/indonesia/indonesia-39780294
  54. Yankey, B, R Rothenberg, S Strasser, K White, and I Okosun. “Relationship between Years of Marijuana Use and the Four Main Diagnostic Criteria for Metabolic Syndrome among United States Adults.” Journal of Addiction Research & Therapy 11, no. 1 (2017): 22–34. https://doi.org/10.4172/2155-6105.1000S11-017

Last update:

No citation recorded.

Last update: 2025-01-20 05:35:59

No citation recorded.